RFID: The Cure For The Clinical Trial Blues

By Joe Pleshek, President & CEO

RFID is making its way into more and more industries as the technology matures and enterprises discover new use cases with solid ROIs. With a strong customer base in the life sciences sector, we see new markets developing rapidly for the technology.

That’s especially true in the world of clinical trials, where RFID could help speed drugs to market and sharply reduce drug development costs by making trials more efficient and accurate. Greater visibility into the entire clinical trial supply chain is essential for a process that results in pharmaceutical firms often spending hundred of millions – if not billions – to get drugs to the stage where they are ready for regulatory approval.

Accountability for investigational drugs and devices in development during clinical trials are not only required by regulations, but also confirm study data integrity and accuracy. Almost always this 2 ©Terso Solutions, Inc. accountability is completed manually with pen and paper. Frequently this critical documentation is incomplete and contains errors.